{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:10:12Z","timestamp":1784675412982,"version":"3.55.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,20]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To determine whether patients with polymyalgia rheumatica (PMR) are more susceptible to glucocorticoid-induced adrenal insufficiency, one of the barriers to glucocorticoid tapering strategies, compared to patients with rheumatoid arthritis (RA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This cross-sectional study included PMR and RA patients who underwent adrenocorticotropic hormone (ACTH) tests to assess adrenal function. The eligibility criteria were as follows: previous use of prednisolone (PSL)\u2009\u2265\u20095\u2009mg\/day, use of PSL for six consecutive months before ACTH test, and current use of PSL at 5\u2009mg\/day or less. The association between disease type (PMR vs. RA) and insufficient adrenal response was assessed using logistic regression models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Twenty-six of 34 (76.5%) patients with PMR and 13 of 37 (35.1%) patients with RA had insufficient adrenal response. Compared to patients with RA, patients with PMR were more likely to have insufficient adrenal response, even after adjusting for age, sex, and PSL dose (adjusted odds ratio, 6.75; 95% confidence interval, 1.78\u201325.60).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Patients with PMR have a higher risk of glucocorticoid-induced adrenal insufficiency than patients with RA. Assessing the adrenal function in patients with PMR will contribute to establishing a more appropriate glucocorticoid reduction strategy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/mr\/roab091","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T22:02:05Z","timestamp":1642543325000},"page":"891-898","source":"Crossref","is-referenced-by-count":6,"title":["Risk of adrenal insufficiency in patients with polymyalgia rheumatica versus patients with rheumatoid arthritis: A cross-sectional study"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8981-7767","authenticated-orcid":false,"given":"Akiko","family":"Kasahara","sequence":"first","affiliation":[{"name":"Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine , Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kida","sequence":"additional","affiliation":[{"name":"Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine , Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko","family":"Hirano","sequence":"additional","affiliation":[{"name":"Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine , Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Omura","sequence":"additional","affiliation":[{"name":"Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine , Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Sofue","sequence":"additional","affiliation":[{"name":"Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine , Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Sakashita","sequence":"additional","affiliation":[{"name":"Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine , Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Sagawa","sequence":"additional","affiliation":[{"name":"Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine , Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine , Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Fukui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine , Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Wada","sequence":"additional","affiliation":[{"name":"Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine , Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Kohno","sequence":"additional","affiliation":[{"name":"Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine , Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Kawahito","sequence":"additional","affiliation":[{"name":"Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine , Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"key":"2022082013391489800_R1","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","article-title":"2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"74","author":"Dejaco","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2022082013391489800_R2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41584-020-0458-5","article-title":"Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica","volume":"16","author":"Camellino","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2022082013391489800_R3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.rdc.2015.08.009","article-title":"Glucocorticoids for management of polymyalgia rheumatica and giant cell arteritis","volume":"42","author":"Matteson","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"2022082013391489800_R4","doi-asserted-by":"crossref","DOI":"10.1186\/ar4686","article-title":"The value of glucocorticoid co-therapy in different rheumatic diseases\u2014positive and adverse effects","volume":"16","author":"van der Goes","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2022082013391489800_R5","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/rheumatology\/ker410","article-title":"Glucocorticoid use and abuse in SLE","volume":"51","author":"Ruiz-Irastorza","year":"2012","journal-title":"Rheumatology"},{"key":"2022082013391489800_R6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2022082013391489800_R7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","article-title":"Update omicronn the diagnosis and management of systemic lupus erythematosus","volume":"80","author":"Fanouriakis","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2022082013391489800_R8","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/jc.2015-1218","article-title":"Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis","volume":"100","author":"Broersen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2022082013391489800_R9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.semarthrit.2016.03.001","article-title":"Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review","volume":"46","author":"Joseph","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"2022082013391489800_R10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Schacke","year":"2002","journal-title":"Pharmacol Ther"},{"key":"2022082013391489800_R11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/s10165-005-0453-3","article-title":"Adrenocorticotropic hormone and dehydroepiandrosterone sulfate levels of rheumatoid arthritis patients treated with glucocorticoids","volume":"16","author":"Yukioka","year":"2006","journal-title":"Mod Rheumatol"},{"key":"2022082013391489800_R12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/s10165-004-0311-8","article-title":"Adrenocorticotropic hormone response to hypoglycemic stress was preserved by a single bedtime 3-mg dose of prednisolone in patients with rheumatoid arthritis","volume":"14","author":"Kuroki","year":"2004","journal-title":"Mod Rheumatol"},{"key":"2022082013391489800_R13","first-page":"65","article-title":"Relapse in a population based cohort of patients with polymyalgia rheumatica","volume":"32","author":"Kremers","year":"2005","journal-title":"J Rheumatol"},{"key":"2022082013391489800_R14","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1001\/archinternmed.2009.352","article-title":"Treatment of polymyalgia rheumatica: a systematic review","volume":"169","author":"Hernandez-Rodriguez","year":"2009","journal-title":"Arch Intern Med"},{"key":"2022082013391489800_R15","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(17)31825-1","article-title":"Polymyalgia rheumatica","volume":"390","author":"Gonz\u00e1lez-Gay","year":"2017","journal-title":"Lancet"},{"key":"2022082013391489800_R16","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/rheumatology\/kep395","article-title":"Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study","volume":"49","author":"Mackie","year":"2010","journal-title":"Rheumatology"},{"key":"2022082013391489800_R17","first-page":"1","article-title":"Glucocorticoid withdrawal in polymyalgia rheumatica: the theory versus the practice","volume":"35","author":"Yates","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"2022082013391489800_R18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/03009740500474586","article-title":"Evaluation of the hypothalamic-pituitary-adrenal axis in untreated patients with polymyalgia rheumatica and healthy controls","volume":"35","author":"Demir","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"2022082013391489800_R19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/14397595.2020.1777680","article-title":"Predictors of long-term therapy with glucocorticoid in polymyalgia rheumatica","volume":"31","author":"Aoki","year":"2021","journal-title":"Mod Rheumatol"},{"key":"2022082013391489800_R20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/ard.2010.133850","article-title":"Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus","volume":"70","author":"Dejaco","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2022082013391489800_R21","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/rheumatology\/39.6.624","article-title":"The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica","volume":"39","author":"Straub","year":"2000","journal-title":"Rheumatology"},{"key":"2022082013391489800_R22","first-page":"655","article-title":"Polymyalgia rheumatica: evidence for a hypothalamic-pituitary-adrenal axis-driven disease","volume":"18","author":"Cutolo","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"2022082013391489800_R23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4137\/JCM.S6215","article-title":"A case of transient ACTH deficiency associated with polymyalgia rheumatica","volume":"1","author":"Nishi","year":"2010","journal-title":"Jpn Clin Med"},{"key":"2022082013391489800_R24","first-page":"19","article-title":"Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica","volume":"25","author":"Cutolo","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"2022082013391489800_R25","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1053\/sarh.2003.49993","article-title":"Hypothalamic-pituitary-adrenocortical axis function in patients with polymyalgia rheumatica and giant cell arteritis","volume":"32","author":"Pacheco","year":"2003","journal-title":"Semin Arthritis Rheum"},{"key":"2022082013391489800_R26","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1093\/rheumatology\/keaa011","article-title":"Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach","volume":"59","author":"Borresen","year":"2020","journal-title":"Rheumatology"},{"key":"2022082013391489800_R27","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/66da2350-2981-489a-932d-3a456c8d0e49","article-title":"Recovery of adrenal function after long-term glucocorticoid therapy for giant cell arteritis: a cohort study","volume":"8","author":"Jamilloux","year":"2013","journal-title":"PLoS One"},{"key":"2022082013391489800_R28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/cen.14405","article-title":"Evaluating tertiary adrenal insufficiency in rheumatology patients on long-term systemic glucocorticoid treatment","volume":"94","author":"Sagar","year":"2021","journal-title":"Clin Endocrinol"},{"key":"2022082013391489800_R29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","article-title":"2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"71","author":"Dasgupta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2022082013391489800_R30","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2022082013391489800_R31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/cen.12039","article-title":"Method-specific serum cortisol responses to the adrenocorticotrophin test: comparison of gas chromatography-mass spectrometry and five automated immunoassays","volume":"78","author":"El-Farhan","year":"2013","journal-title":"Clin Endocrinol"},{"key":"2022082013391489800_R32","article-title":"New cutoffs for the biochemical diagnosis of adrenal insufficiency after ACTH stimulation using specific cortisol assays","volume":"5","author":"Javorsky","year":"2021","journal-title":"J Endocr Soc"},{"key":"2022082013391489800_R33","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/EDE.0000000000000864","article-title":"Web site and R package for computing E-values","volume":"29","author":"Mathur","year":"2018","journal-title":"Epidemiology"},{"key":"2022082013391489800_R34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"2022082013391489800_R35","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2018"},{"key":"2022082013391489800_R36","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7326\/0003-4819-82-5-613","article-title":"Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study","volume":"82","author":"Hunder","year":"1975","journal-title":"Ann Intern Med"},{"key":"2022082013391489800_R37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1530\/EJE-17-0251","article-title":"Adrenal insufficiency is seen in more than one-third of patients during ongoing low-dose prednisolone treatment for rheumatoid arthritis","volume":"177","author":"Borresen","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"2022082013391489800_R38","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s10067-005-0188-8","article-title":"The role of anticyclic citrullinated peptide antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica","volume":"25","author":"Ceccato","year":"2006","journal-title":"Clin Rheumatol"},{"key":"2022082013391489800_R39","first-page":"750","article-title":"The relation of polymyalgia rheumatica to rheumatoid arthritis","volume":"15","author":"Healey","year":"1988","journal-title":"J Rheumatol"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mr\/advance-article-pdf\/doi\/10.1093\/mr\/roab091\/43434962\/roab091.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/32\/5\/891\/45487161\/roab091.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/32\/5\/891\/45487161\/roab091.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T13:40:02Z","timestamp":1661002802000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/32\/5\/891\/6511018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,18]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,1,18]]},"published-print":{"date-parts":[[2022,8,20]]}},"URL":"https:\/\/doi.org\/10.1093\/mr\/roab091","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,1]]},"published":{"date-parts":[[2022,1,18]]}}}